Roivant Sciences (ROIV) Asset Utilization Ratio (2021 - 2025)
Roivant Sciences (ROIV) reported Asset Utilization Ratio of 0.0 for Q4 2025, down 53.54% on a YoY basis from 0.01 in Q4 2024, and down 15.97% quarter-over-quarter from 0.0 in Q3 2025.
Roivant Sciences (ROIV) Asset Utilization Ratio (2021 - 2025) Analysis & Trends
Roivant Sciences has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.0 in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio fell 53.54% year-over-year to 0.0; the trailing twelve-month figure through Dec 2025 stood at 0.0 (down 53.54% YoY), and the FY2026 full-year result was 0.0, down 70.8% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.0, down from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.03 in Q4 2022, with the low at 0.0 in Q4 2025.
- Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2021.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio surged 199.14% — and 2024, when it plunged 80.9%.
- Roivant Sciences' Asset Utilization Ratio stood at 0.02 in 2021, then surged by 50.16% to 0.03 in 2022, then plunged by 53.18% to 0.01 in 2023, then plunged by 49.98% to 0.01 in 2024, then tumbled by 53.54% to 0.0 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |